Formulation and Quality – Biomolecular
It's not only your biological entity that patients need - your entity also needs to be administered to patients. Where do you get your administration device from? Do you license it from a partner, or do you develop and build it yourself? What are the ramifications for product development, what does it mean for approval processes, what does this mean for your product liability? How does it influence time and costs of your development?
This session will highlight pros and cons of either approach. It is a panel discussion, and you can ask your specific questions or share your experience for this strategic matter. International specialists will be on the panel to answer your questions; they will provide arguments and give insight into the right timing.
This panel is of strategic importance for your sound development plan! Come and join us!